« previous next »
Pages: [1]

Author Topic: (AAN) Biogen says new MS drug Vumerity (diroximel fumarate) under FDA review  (Read 122 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9842
  • MS diagnosed 1980
  • Location: Pacific Northwest
(AAN) Biogen says new MS drug Vumerity (diroximel fumarate) under FDA review
« on: May 15, 2019, 04:14:03 pm »
Neurofilament light chains received quite a bit of attention at the annual AAN conference for 2019 (Philadelphia, May 4-10). They're mentioned in this article from Multiple Sclerosis News Today (May 15, 2019) entitled "Biogen Offers Update on Development Plans for MS Therapies." The Biogen spokesperson is announcing another new MS drug, Vumerity, which is up for FDA review:


http://bit.ly/2vZW9t9
« Last Edit: April 07, 2021, 08:40:18 pm by agate »
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
156 Views 		Last post August 11, 2016, 09:54:08 am
by agate
0 Replies
563 Views 		Last post July 21, 2017, 03:21:38 pm
by agate
0 Replies
107 Views 		Last post October 31, 2019, 08:49:09 am
by agate
0 Replies
26 Views 		Last post July 26, 2022, 09:46:13 pm
by agate
0 Replies
32 Views 		Last post October 28, 2022, 09:38:35 pm
by agate